Condition
Virus Diseases
ClinicalTrials.gov condition label
Clinical trials
9 shownEffectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPDNCT07393685 · 2026-08-01
NOT_YET_RECRUITINGRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionNCT06149494 · 2023-11-20
COMPLETEDSelf-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenNCT04772469 · 2021-03-22
COMPLETEDCongenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesNCT04769167 · 2021-02-01
COMPLETEDBacillus Calmette-guérin Vaccination to Prevent COVID-19NCT04414267 · 2020-05-26
COMPLETEDFeasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruNCT02630082 · 2011-04-01
COMPLETEDClinic-based ART Diagnostic EvaluationNCT01791556 · 2010-01-26
COMPLETEDA Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI RegimenNCT00749580 · 2008-11-01
COMPLETEDViral Infections in Chronic Obstructive Pulmonary Disease (COPD) ExacerbationsNCT00448604 · 2007-05-01
COMPLETEDCommon interventions
BCG vaccineBIOLOGICAL1CircumcisionPROCEDURE1Flexible sigmoidoscopyPROCEDURE1Follow-up Medical Record ReviewOTHER1HIV-1 viral load testingOTHER1PlaceboBIOLOGICAL1PlaceboDRUG1Provision of multiple self-testsBEHAVIORAL1Small monetary incentivesOTHER1Standard Antiviral Therapy (Oseltamivir or Baloxavir marboxil)DRUG1Stool and Blood Specimen CollectionOTHER1Switch NRTIs as a Backbone to RaltegravirDRUG1Use of SMS/text reminders to motivate adherence to ART or PrEPBEHAVIORAL1VapendavirDRUG1Xuanfei Jiangzhuo DecoctionDRUG1
Leading sponsors
Altesa Biosciences, Inc.1Hellenic Institute for the Study of Sepsis1National Institute of Allergy and Infectious Diseases (NIAID)1Tianjin Medical University1University Hospital, Geneva1University of California, San Francisco1University of South Florida1Walter Reed Army Institute of Research (WRAIR)1Washington University School of Medicine1
Trial status mix
COMPLETED8
NOT_YET_RECRUITING1
Phase mix
NA5
PHASE21
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.